The Patient's Guide to Glaucoma is a very useful educational resource. The authors have done an excellent job of covering the pertinent aspects of glaucoma from the patient's perspective. It provides more complete explanations of aspects of glaucoma care than any other presently available resource. It will be very helpful to patients who want more information about medications, laser, trabeculectomy, tube-shunt surgery, and many other subjects. John S. Cohen, MD Director, Glaucoma Service Cincinnati Eye Institute, Volunteer Clinical Professor University of Cincinnati Drs. Kwon, Greenlee and Fingert are to be congratulated for creating this outstanding educational program on glaucoma. These materials provide an excellent overview of the disease and its treatment. The guide can be read in its entirety or searched to answer specific questions. It is aimed at the intelligent patient seeking to understand his or her disease. The ophthalmologist's best ally in battling glaucoma is a well-informed patient and this guide will serve to develop patients who truly understand their disease. W.L.M. Alward, MD The Frederick C. Blodi Chair in Ophthalmology, Professor of Ophthalmology, Vice-Chair, Dept of Ophthalmology & Visual Sciences, University of Iowa

Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€"as well as the people who care for themâ€"with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€"in short, anyone who wants to learn more about this important issue.

This book serves as an introductory reference on clinical aspects of glaucoma and myopia, providing essential guidelines for diagnosis and monitoring of glaucoma progression in patients, especially those with high myopias. Many clinical studies are presented by leading experts in the field in an accessible style, making the content suitable not only for ophthalmologists but also for optometrists and certified orthoptists as well as for students. The relation between myopia and glaucoma has been the subject of many clinical trials and population-based studies. Most of the data has suggested that moderate to high myopia is associated with increased risk of primary open-angle glaucoma, normal tension glaucoma, and ocular hypertension. There are several factors involved in the diagnosis of glaucoma, but it is often difficult to determine the presence of glaucoma in myopic eyes. A myopic eye, especially in cases of moderate to high myopia, tends to have a thin retina and choroid and to appear thinner than normal. Even with new imaging technologies with improved sensitivity and specificity for detecting glaucoma, each technology presents some challenges when assessing myopic eyes. This book furnishes an overview of these diagnostic challenges with reference to the growing prevalence and severity of myopia in various parts of the world, providing many valuable hands-on reports and clinical studies by authoritative authors. This knowledge will help to do away with the vague area between high myopia and glaucoma faced by clinicians.

Preface Childhood is the topic of the ninth World Glaucoma Association Consensus. There has been only sparse attention to the diagnosis and treatment of childhood glaucoma. Both pediatric ophthalmologists and glaucoma specialists provide care for such children. In some instances, they manage these individuals alone and, in others, the management is shared. For this consensus, the participation of both groups was solicited. The global faculty, consisting of leading authorities on the clinical and scientific aspects of childhood glaucoma, met in Vancouver on July 16, 2013, just prior to the World Glaucoma Congress, to discuss the reports and refine the consensus statements. As with prior meetings, it was a daunting task to seek and obtain consensus on such a complicated and nuanced subject. It is unclear how each of us decides how we practice, and evidence to guide us often is sparse. It is remarkable how few high level studies have been conducted on the management of childhood glaucoma. Hence, this consensus, as with the others, is based not only on the published literature, but also on expert opinion. Although consensus does not replace and is not a surrogate for scientific investigation, it does provide considerable value, especially when the desired evidence is lacking. The goal of this consensus was to provide a foundation for diagnosing and treating childhood glaucoma and how it can be best done in clinical practice. Identification of those areas for which we have little evidence and, therefore, the need for additional research also was a high priority. We hope that this consensus report will serve as a benchmark of our understanding. However, this consensus report, as with each of the others, is intended to be just a beginning. It is expected that it will be revised and improved with the emergence of new evidence. Robert N. Weinreb, Chair

This atlas offers a truly comprehensive update on the use of imaging technologies for the diagnosis and follow-up of glaucoma. In addition to standard automated perimetry, gonioscopy, fundus photography, and stereophotography, other advanced, high-resolution methods for imaging the eye in glaucoma are explained in detail, including ultrasound biomicroscopy, confocal scanning laser ophthalmoscopy, scanning laser polarimetry, and spectral domain optical coherence tomography. The role of the various tests and the keys to optimizing their use in clinical practice are detailed with the aid of high-quality figures in order to enable the reader to achieve the best possible performance when applying these tools. The risk of developing visual disability and blindness as a consequence of glaucoma varies widely among affected individuals. Personalized testing strategies and tailored therapeutic interventions are required to effectively reduce visual impairment due to glaucoma. Glaucoma Imaging will assist residents, researchers, and clinicians in improving their ability to understand and integrate the information obtained using traditional techniques with the reports provided by computer-assisted image instruments.